2010 Annual Meeting
(621f) Can A Design Space Be Built On Material Attributes Alone?
Authors
James N. Michaels - Presenter, Merck and Co. Inc.
Holly Bonsignore - Presenter, Pfizer Inc.
Buffy L. Hudson-Curtis - Presenter, GlaxoSmithKline
Steven Laurenz - Presenter, Abbott Laboratories
Thomas Mathai - Presenter, Cephalon
Girish Pande - Presenter, GlaxoSmithKline
Ashlesh Sheth - Presenter, Merck & Co., Inc.
Omar Sprockel - Presenter, Bristol-Myers Squibb Company
Homer Lin - Presenter, Amgen
In April, 2009, the PhRMA Drug Product Technical Group sponsored an industry workshop to explore the practicality and limitations of defining a design space in terms of material attributes rather than process variables. This presentation summarizes and expands on the output of this workshop. A material-attribute design space would be independent of scale and configuration of process equipment and the associated process variables. For this reason, it would be portable in the sense that post-approval changes of equipment scale, nameplate, or location would not require regulatory approval. A hypothetical case study of an immediate release oral tablet is presented to illustrate how such a design space could be constructed and implemented.